 Colleen McIlvennan
Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 55 | 2024 | 533 | 11.500 |
Why?
| | Heart Failure | 76 | 2025 | 2150 | 8.880 |
Why?
| | Caregivers | 23 | 2024 | 807 | 4.760 |
Why?
| | Decision Making | 15 | 2023 | 850 | 2.200 |
Why?
| | Terminal Care | 10 | 2022 | 238 | 2.180 |
Why?
| | Heart Transplantation | 8 | 2024 | 710 | 1.620 |
Why?
| | Palliative Care | 9 | 2024 | 716 | 1.550 |
Why?
| | Quality of Life | 20 | 2024 | 2680 | 1.380 |
Why?
| | Ventricular Function, Left | 4 | 2020 | 525 | 1.130 |
Why?
| | Ventricular Dysfunction, Left | 5 | 2023 | 386 | 1.040 |
Why?
| | Choice Behavior | 2 | 2020 | 164 | 1.030 |
Why?
| | Delivery of Health Care | 4 | 2023 | 892 | 1.000 |
Why?
| | Patient Care Team | 5 | 2024 | 600 | 0.980 |
Why?
| | Cardiology | 2 | 2019 | 267 | 0.980 |
Why?
| | Health Knowledge, Attitudes, Practice | 7 | 2024 | 1271 | 0.970 |
Why?
| | Thrombosis | 3 | 2021 | 321 | 0.900 |
Why?
| | Humans | 96 | 2025 | 128524 | 0.860 |
Why?
| | Heart Injuries | 1 | 2023 | 35 | 0.820 |
Why?
| | Stress, Psychological | 3 | 2021 | 1058 | 0.820 |
Why?
| | Physician-Patient Relations | 4 | 2024 | 530 | 0.810 |
Why?
| | Registries | 6 | 2024 | 1878 | 0.800 |
Why?
| | Emotions | 6 | 2023 | 533 | 0.800 |
Why?
| | Patient Participation | 7 | 2025 | 407 | 0.790 |
Why?
| | Middle Aged | 36 | 2024 | 30893 | 0.690 |
Why?
| | Prosthesis Implantation | 3 | 2019 | 143 | 0.690 |
Why?
| | Patient Preference | 6 | 2024 | 184 | 0.680 |
Why?
| | Palliative Medicine | 2 | 2017 | 15 | 0.680 |
Why?
| | Health Literacy | 3 | 2024 | 162 | 0.670 |
Why?
| | Delirium | 1 | 2021 | 77 | 0.670 |
Why?
| | Patient Readmission | 2 | 2015 | 664 | 0.640 |
Why?
| | Biomedical Research | 3 | 2020 | 646 | 0.630 |
Why?
| | Attitude to Death | 2 | 2016 | 68 | 0.610 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 339 | 0.610 |
Why?
| | Coronavirus Infections | 2 | 2020 | 335 | 0.600 |
Why?
| | Risk Assessment | 6 | 2020 | 3256 | 0.600 |
Why?
| | Betacoronavirus | 2 | 2020 | 249 | 0.600 |
Why?
| | Patient Acceptance of Health Care | 3 | 2020 | 764 | 0.590 |
Why?
| | Surveys and Questionnaires | 9 | 2024 | 5346 | 0.570 |
Why?
| | Male | 44 | 2024 | 62883 | 0.560 |
Why?
| | Hospice Care | 3 | 2016 | 199 | 0.560 |
Why?
| | Decision Making, Computer-Assisted | 1 | 2017 | 18 | 0.560 |
Why?
| | Aged | 27 | 2024 | 21971 | 0.550 |
Why?
| | Patients | 2 | 2023 | 166 | 0.540 |
Why?
| | Caliciviridae Infections | 1 | 2016 | 17 | 0.540 |
Why?
| | Hospital Records | 1 | 2016 | 10 | 0.530 |
Why?
| | Qualitative Research | 7 | 2024 | 1205 | 0.530 |
Why?
| | Female | 44 | 2024 | 68127 | 0.530 |
Why?
| | Quality Improvement | 4 | 2021 | 1100 | 0.530 |
Why?
| | Mexiletine | 1 | 2016 | 7 | 0.530 |
Why?
| | Amphetamine | 1 | 2016 | 24 | 0.520 |
Why?
| | Adaptation, Psychological | 9 | 2024 | 612 | 0.510 |
Why?
| | Physicians | 4 | 2020 | 860 | 0.500 |
Why?
| | Bereavement | 1 | 2016 | 50 | 0.500 |
Why?
| | Hospitalization | 4 | 2021 | 2071 | 0.500 |
Why?
| | Clinical Decision-Making | 2 | 2024 | 302 | 0.500 |
Why?
| | Myocardial Infarction | 1 | 2023 | 1014 | 0.500 |
Why?
| | Cryosurgery | 1 | 2016 | 54 | 0.490 |
Why?
| | Substance Abuse Detection | 1 | 2016 | 73 | 0.490 |
Why?
| | Transplant Recipients | 1 | 2016 | 151 | 0.480 |
Why?
| | Drug Monitoring | 1 | 2016 | 184 | 0.470 |
Why?
| | Patient-Centered Care | 4 | 2021 | 493 | 0.460 |
Why?
| | Partial Thromboplastin Time | 1 | 2014 | 49 | 0.460 |
Why?
| | Depression | 2 | 2021 | 1289 | 0.460 |
Why?
| | Heart Diseases | 2 | 2017 | 345 | 0.450 |
Why?
| | Tachycardia, Ventricular | 1 | 2016 | 169 | 0.450 |
Why?
| | Heart Ventricles | 4 | 2021 | 766 | 0.440 |
Why?
| | Advance Care Planning | 2 | 2017 | 205 | 0.440 |
Why?
| | Decision Support Techniques | 4 | 2020 | 398 | 0.430 |
Why?
| | Stroke Volume | 4 | 2023 | 588 | 0.430 |
Why?
| | Research Design | 1 | 2019 | 1038 | 0.420 |
Why?
| | Adult | 25 | 2024 | 35315 | 0.420 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2025 | 1358 | 0.420 |
Why?
| | United States | 18 | 2025 | 13876 | 0.410 |
Why?
| | Blood Coagulation | 1 | 2014 | 226 | 0.410 |
Why?
| | Pandemics | 2 | 2020 | 1487 | 0.400 |
Why?
| | Informed Consent | 1 | 2014 | 174 | 0.400 |
Why?
| | Attitude to Health | 1 | 2016 | 430 | 0.400 |
Why?
| | Interviews as Topic | 4 | 2024 | 705 | 0.400 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1197 | 0.390 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 2018 | 0.370 |
Why?
| | Treatment Outcome | 12 | 2024 | 10163 | 0.370 |
Why?
| | Anticoagulants | 2 | 2021 | 613 | 0.370 |
Why?
| | Activities of Daily Living | 1 | 2014 | 388 | 0.350 |
Why?
| | American Heart Association | 4 | 2024 | 309 | 0.350 |
Why?
| | Health Personnel | 2 | 2022 | 646 | 0.340 |
Why?
| | Program Development | 2 | 2023 | 362 | 0.300 |
Why?
| | Patient Reported Outcome Measures | 4 | 2024 | 359 | 0.300 |
Why?
| | Social Support | 3 | 2024 | 584 | 0.290 |
Why?
| | Patient Education as Topic | 3 | 2018 | 734 | 0.280 |
Why?
| | Substance-Related Disorders | 1 | 2016 | 1011 | 0.280 |
Why?
| | Risk Factors | 9 | 2021 | 9727 | 0.270 |
Why?
| | Mental Health | 2 | 2023 | 684 | 0.250 |
Why?
| | Withholding Treatment | 2 | 2016 | 70 | 0.250 |
Why?
| | Communication | 4 | 2024 | 838 | 0.250 |
Why?
| | Cost of Illness | 2 | 2020 | 288 | 0.240 |
Why?
| | Data Collection | 2 | 2019 | 649 | 0.230 |
Why?
| | Troponin | 1 | 2023 | 50 | 0.210 |
Why?
| | Cardiovascular Agents | 1 | 2024 | 151 | 0.200 |
Why?
| | Quality Assurance, Health Care | 1 | 2024 | 316 | 0.190 |
Why?
| | Trust | 1 | 2022 | 115 | 0.180 |
Why?
| | Hospital Mortality | 2 | 2016 | 844 | 0.180 |
Why?
| | Guideline Adherence | 1 | 2025 | 525 | 0.180 |
Why?
| | Survival Rate | 3 | 2024 | 1872 | 0.180 |
Why?
| | Home Nursing | 1 | 2020 | 26 | 0.170 |
Why?
| | BK Virus | 1 | 2019 | 13 | 0.170 |
Why?
| | Thoracentesis | 1 | 2019 | 5 | 0.170 |
Why?
| | Medicare | 2 | 2015 | 718 | 0.160 |
Why?
| | Psychosocial Support Systems | 1 | 2019 | 11 | 0.160 |
Why?
| | Family | 1 | 2023 | 642 | 0.160 |
Why?
| | Retrospective Studies | 11 | 2024 | 14460 | 0.160 |
Why?
| | Data Accuracy | 1 | 2019 | 59 | 0.160 |
Why?
| | Ethics Committees, Research | 1 | 2019 | 41 | 0.160 |
Why?
| | Viremia | 1 | 2019 | 130 | 0.160 |
Why?
| | Motion Pictures | 1 | 2019 | 18 | 0.150 |
Why?
| | Home Infusion Therapy | 1 | 2018 | 4 | 0.150 |
Why?
| | Biomarkers | 2 | 2023 | 3881 | 0.150 |
Why?
| | Device Removal | 1 | 2020 | 137 | 0.150 |
Why?
| | Outpatients | 2 | 2023 | 366 | 0.150 |
Why?
| | Warfarin | 2 | 2021 | 147 | 0.150 |
Why?
| | Chronic Disease | 3 | 2022 | 1701 | 0.150 |
Why?
| | Nurse Practitioners | 2 | 2019 | 127 | 0.150 |
Why?
| | Research Support as Topic | 1 | 2019 | 113 | 0.150 |
Why?
| | Immunocompromised Host | 1 | 2019 | 195 | 0.150 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 857 | 0.140 |
Why?
| | Cardiotonic Agents | 1 | 2018 | 124 | 0.140 |
Why?
| | Renal Insufficiency | 1 | 2019 | 148 | 0.140 |
Why?
| | Aged, 80 and over | 4 | 2024 | 7040 | 0.140 |
Why?
| | Spouses | 1 | 2018 | 99 | 0.140 |
Why?
| | Research Personnel | 1 | 2019 | 160 | 0.140 |
Why?
| | Practice Guidelines as Topic | 1 | 2025 | 1490 | 0.140 |
Why?
| | Organ Transplantation | 1 | 2020 | 219 | 0.140 |
Why?
| | Diphenoxylate | 1 | 2016 | 5 | 0.140 |
Why?
| | Atropine | 1 | 2016 | 24 | 0.140 |
Why?
| | Loperamide | 1 | 2016 | 10 | 0.140 |
Why?
| | Antidiarrheals | 1 | 2016 | 14 | 0.140 |
Why?
| | Nursing Assessment | 1 | 2017 | 53 | 0.140 |
Why?
| | Prospective Studies | 3 | 2020 | 7043 | 0.140 |
Why?
| | Pressure Ulcer | 1 | 2017 | 35 | 0.130 |
Why?
| | Periodicals as Topic | 1 | 2019 | 206 | 0.130 |
Why?
| | Follow-Up Studies | 6 | 2024 | 4898 | 0.130 |
Why?
| | Cause of Death | 1 | 2018 | 391 | 0.130 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 278 | 0.130 |
Why?
| | Terminally Ill | 1 | 2016 | 35 | 0.130 |
Why?
| | Voltage-Gated Sodium Channel Blockers | 1 | 2016 | 5 | 0.130 |
Why?
| | Patient Care Management | 1 | 2016 | 56 | 0.130 |
Why?
| | Mineralocorticoid Receptor Antagonists | 1 | 2016 | 45 | 0.130 |
Why?
| | Chromatography, Gas | 1 | 2016 | 31 | 0.130 |
Why?
| | Consumer Health Information | 1 | 2016 | 48 | 0.130 |
Why?
| | Gastrointestinal Agents | 1 | 2016 | 60 | 0.130 |
Why?
| | Advanced Practice Nursing | 1 | 2016 | 28 | 0.130 |
Why?
| | Atrial Fibrillation | 1 | 2021 | 378 | 0.130 |
Why?
| | Prosthesis Design | 2 | 2016 | 308 | 0.130 |
Why?
| | Mortality | 1 | 2018 | 307 | 0.130 |
Why?
| | Defibrillators, Implantable | 2 | 2016 | 295 | 0.130 |
Why?
| | Health Policy | 2 | 2020 | 353 | 0.130 |
Why?
| | Canada | 1 | 2017 | 345 | 0.130 |
Why?
| | Truth Disclosure | 1 | 2016 | 44 | 0.130 |
Why?
| | Referral and Consultation | 1 | 2021 | 727 | 0.130 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 317 | 0.120 |
Why?
| | Social Security | 1 | 2015 | 5 | 0.120 |
Why?
| | Uncertainty | 1 | 2016 | 114 | 0.120 |
Why?
| | Drug Combinations | 1 | 2016 | 323 | 0.120 |
Why?
| | Hospices | 1 | 2016 | 89 | 0.120 |
Why?
| | Medical Indigency | 1 | 2015 | 11 | 0.120 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3023 | 0.120 |
Why?
| | Sex Distribution | 1 | 2016 | 359 | 0.120 |
Why?
| | Diagnosis-Related Groups | 1 | 2015 | 27 | 0.120 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 201 | 0.120 |
Why?
| | Patient Care Planning | 1 | 2016 | 148 | 0.120 |
Why?
| | Patient Selection | 1 | 2019 | 661 | 0.120 |
Why?
| | Health Care Costs | 1 | 2018 | 395 | 0.120 |
Why?
| | Nurse's Role | 1 | 2016 | 139 | 0.120 |
Why?
| | Workload | 1 | 2016 | 150 | 0.120 |
Why?
| | Multimedia | 1 | 2014 | 10 | 0.120 |
Why?
| | Factor X | 1 | 2014 | 25 | 0.120 |
Why?
| | Fee-for-Service Plans | 1 | 2015 | 88 | 0.120 |
Why?
| | Assisted Circulation | 1 | 2014 | 25 | 0.120 |
Why?
| | Central Nervous System Stimulants | 1 | 2016 | 156 | 0.110 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 316 | 0.110 |
Why?
| | Treatment Refusal | 1 | 2015 | 87 | 0.110 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2015 | 101 | 0.110 |
Why?
| | Needs Assessment | 1 | 2016 | 360 | 0.110 |
Why?
| | Family Relations | 1 | 2015 | 89 | 0.110 |
Why?
| | Disease Progression | 2 | 2025 | 2603 | 0.110 |
Why?
| | Population Surveillance | 1 | 2017 | 427 | 0.110 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1019 | 0.110 |
Why?
| | Patient Discharge | 2 | 2022 | 849 | 0.110 |
Why?
| | Sex Factors | 2 | 2016 | 1949 | 0.110 |
Why?
| | Prognosis | 5 | 2024 | 3780 | 0.110 |
Why?
| | Mass Screening | 1 | 2021 | 1152 | 0.110 |
Why?
| | Risk | 1 | 2016 | 852 | 0.110 |
Why?
| | Cooperative Behavior | 1 | 2016 | 425 | 0.110 |
Why?
| | Length of Stay | 2 | 2017 | 1121 | 0.110 |
Why?
| | Pain Management | 1 | 2016 | 319 | 0.100 |
Why?
| | Heparin | 1 | 2014 | 240 | 0.100 |
Why?
| | Cohort Studies | 1 | 2023 | 5369 | 0.100 |
Why?
| | Antibodies | 1 | 2014 | 391 | 0.100 |
Why?
| | Imaging, Three-Dimensional | 1 | 2016 | 534 | 0.100 |
Why?
| | Immunosuppressive Agents | 1 | 2016 | 686 | 0.100 |
Why?
| | Program Evaluation | 1 | 2016 | 874 | 0.100 |
Why?
| | Severity of Illness Index | 2 | 2017 | 2736 | 0.100 |
Why?
| | Acute Disease | 1 | 2014 | 968 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1266 | 0.090 |
Why?
| | Pilot Projects | 1 | 2016 | 1558 | 0.090 |
Why?
| | Time Factors | 4 | 2024 | 6503 | 0.090 |
Why?
| | Health Behavior | 1 | 2016 | 740 | 0.090 |
Why?
| | Motivation | 1 | 2015 | 537 | 0.090 |
Why?
| | Internet | 1 | 2014 | 618 | 0.080 |
Why?
| | Prevalence | 1 | 2016 | 2549 | 0.080 |
Why?
| | Comorbidity | 3 | 2020 | 1540 | 0.080 |
Why?
| | Attitude of Health Personnel | 1 | 2016 | 1090 | 0.080 |
Why?
| | Incidence | 1 | 2014 | 2619 | 0.070 |
Why?
| | Bayes Theorem | 2 | 2019 | 368 | 0.070 |
Why?
| | Academic Medical Centers | 2 | 2020 | 473 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 2521 | 0.060 |
Why?
| | Disease Management | 2 | 2022 | 588 | 0.060 |
Why?
| | Postoperative Complications | 3 | 2024 | 2479 | 0.060 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5040 | 0.060 |
Why?
| | Michigan | 1 | 2024 | 103 | 0.060 |
Why?
| | Shock, Cardiogenic | 1 | 2024 | 59 | 0.050 |
Why?
| | Congresses as Topic | 1 | 2025 | 214 | 0.050 |
Why?
| | Young Adult | 2 | 2016 | 12320 | 0.050 |
Why?
| | Information Systems | 1 | 2023 | 62 | 0.050 |
Why?
| | Comprehension | 1 | 2024 | 166 | 0.050 |
Why?
| | Patient Care | 1 | 2023 | 110 | 0.050 |
Why?
| | Death | 1 | 2022 | 122 | 0.050 |
Why?
| | Consensus | 1 | 2024 | 633 | 0.050 |
Why?
| | Aftercare | 1 | 2022 | 205 | 0.040 |
Why?
| | Health Services Misuse | 1 | 2020 | 36 | 0.040 |
Why?
| | Role | 1 | 2020 | 33 | 0.040 |
Why?
| | Age Factors | 2 | 2019 | 3117 | 0.040 |
Why?
| | Hospitals, Community | 1 | 2020 | 49 | 0.040 |
Why?
| | Thromboembolism | 1 | 2021 | 102 | 0.040 |
Why?
| | Pharmacogenomic Testing | 1 | 2020 | 59 | 0.040 |
Why?
| | Social Responsibility | 1 | 2020 | 47 | 0.040 |
Why?
| | Income | 1 | 2020 | 189 | 0.040 |
Why?
| | Tertiary Care Centers | 1 | 2020 | 147 | 0.040 |
Why?
| | Contraindications, Procedure | 1 | 2019 | 11 | 0.040 |
Why?
| | Contracts | 1 | 2019 | 11 | 0.040 |
Why?
| | Visual Analog Scale | 1 | 2019 | 29 | 0.040 |
Why?
| | Pharmacogenetics | 1 | 2020 | 171 | 0.040 |
Why?
| | Self Efficacy | 1 | 2022 | 369 | 0.040 |
Why?
| | International Cooperation | 1 | 2019 | 173 | 0.040 |
Why?
| | Area Under Curve | 1 | 2019 | 281 | 0.040 |
Why?
| | Administration, Oral | 1 | 2021 | 757 | 0.040 |
Why?
| | Survival | 1 | 2018 | 39 | 0.040 |
Why?
| | Colorado | 2 | 2020 | 4392 | 0.040 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 260 | 0.040 |
Why?
| | Walk Test | 1 | 2018 | 69 | 0.040 |
Why?
| | Health Status | 1 | 2023 | 751 | 0.040 |
Why?
| | Viral Load | 1 | 2019 | 450 | 0.040 |
Why?
| | ROC Curve | 1 | 2019 | 501 | 0.040 |
Why?
| | Social Determinants of Health | 1 | 2020 | 217 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 346 | 0.040 |
Why?
| | Equipment Design | 1 | 2019 | 518 | 0.040 |
Why?
| | Infusions, Intravenous | 1 | 2018 | 384 | 0.030 |
Why?
| | Adolescent | 1 | 2016 | 20213 | 0.030 |
Why?
| | Intraoperative Care | 1 | 2017 | 45 | 0.030 |
Why?
| | Health Surveys | 1 | 2019 | 492 | 0.030 |
Why?
| | Nurses | 1 | 2019 | 163 | 0.030 |
Why?
| | Hemorrhage | 1 | 2021 | 644 | 0.030 |
Why?
| | Frail Elderly | 1 | 2017 | 119 | 0.030 |
Why?
| | Postoperative Care | 1 | 2017 | 243 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1416 | 0.030 |
Why?
| | Video Recording | 1 | 2016 | 164 | 0.030 |
Why?
| | Life Change Events | 1 | 2016 | 148 | 0.030 |
Why?
| | Societies, Medical | 1 | 2019 | 749 | 0.030 |
Why?
| | Reference Values | 1 | 2016 | 780 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2018 | 506 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 998 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2019 | 704 | 0.030 |
Why?
| | Databases, Factual | 1 | 2019 | 1268 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1265 | 0.030 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2019 | 564 | 0.030 |
Why?
| | Stroke | 1 | 2021 | 1064 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2016 | 607 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1616 | 0.020 |
Why?
| | Telemedicine | 1 | 2020 | 778 | 0.020 |
Why?
| | Body Mass Index | 1 | 2019 | 2262 | 0.020 |
Why?
| | Anxiety | 1 | 2016 | 949 | 0.020 |
Why?
| | Cognition | 1 | 2016 | 1107 | 0.020 |
Why?
| | Hypertension, Pulmonary | 1 | 2019 | 1735 | 0.020 |
Why?
| | Child | 1 | 2022 | 20721 | 0.010 |
Why?
|
|
McIlvennan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|